Loading clinical trials...
Loading clinical trials...
The project has the following general aims: 1. Natural course and prognosis: To prospectively follow the natural course and prognosis of the different types of PFIC, to broaden the understanding of t...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Medical Center Groningen
NCT07185919 · Progressive Familial Intrahepatic Cholestasis
NCT07191704 · PFIC - Progressive Familial Intrahepatic Cholestasis
NCT07293897 · Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT06781242 · Cholestatic Liver Disease, Intrahepatic Cholestasis, and more
NCT06777914 · Hepatobiliary Cancers, Progressive Familial Intrahepatic Cholestasis (PFIC), and more
University Medical Center Groningen
Groningen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions